Research describes advantages of new vaccine adjuvant
December 12, 2011 in Medical research
New research from the laboratory of Dr. Elizabeth Leadbetter at the Trudeau Institute may lead to a whole new class of vaccines. Dr. Leadbetter's lab has discovered new properties of a potential vaccine adjuvant that suggest it could be useful for enhancing protection against a number of different infections. This new data will be published in the January 2012 issue of the journal Nature Immunology (Vol. 13, pp. 44-50). The paper, "iNKT cells direct B cell responses to cognate lipid antigen in an interleukin 21-dependent manner," is now available through Advance Online Publication (AOP) on Nature Immunology's website.
Effective vaccines train our bodies to recognize harmful microbes (such as viruses, bacteria and parasites) and typically contain disabled microbes, or even just components of microbes called antigens. Vaccination tricks our bodies into thinking we have been infected by the harmful microbe, triggering an immune response. Ideally, the vaccine produces a long-lived "memory" immune response to the microbe's antigens. This memory allows our bodies to respond more quickly and effectively if we ever become infected by the harmful microbe.
Most human vaccines contain adjuvants -- substances added to the vaccine to improve immune response to the antigens. Adjuvants increase the strength of the immune response and also allow for smaller amounts of antigens to be used in vaccine production.
Immune response to antigens results in the production of antibodies, which are a secreted product of B cells. Antibodies attach to antigens and help our bodies eliminate harmful microbes. Some T cells can help B cells make antibodies. Dr. Leadbetter previously discovered that natural killer T (NKT) cells, a special population of T cells, can help B cells make antibodies. NKT cells are special because they recognize lipid (fat) antigens. In contrast, most helper T cells recognize protein antigens. Because many harmful microbes produce unique lipids, Dr. Leadbetter hypothesized that directing NKT cells to help B cells could provide a new way to induce antibodies against harmful microbes, which would complement existing vaccine technologies.
Dr. Leadbetter's new studies advance her hypothesis that lipid molecules may serve as promising vaccine components. The studies demonstrate that NKT cells can help B cells produce antibodies that recognize lipids, but this does not result in long-lived memory immune responses to the lipid antigens. Second, the studies demonstrate that the lipids, when used as adjuvants to enhance immune responses to more conventional protein antigens, induce memory immune responses against the protein target without inducing a memory response to the lipid itself. Together, these findings suggest a single lipid adjuvant could be used multiple times without losing its effect. The new research also characterizes how NKT cells help B cells produce antibodies when lipids are used as a vaccine adjuvant.
Lipids may become an important new class of adjuvants not only because of their intrinsic properties but also because of their capacity to activate NKT cells. According to Dr. Leadbetter, "These cells are really fascinating because they have both innate and adaptive immune cell properties. In other words, they act rapidly, but also specifically. NKT cell activation by certain lipids enhances the activation of other immune cells, thus acting as the body's natural adjuvant."
Provided by
Trudeau Institute
-
Natural killers help fight human disease
Nov 28, 2011 |
not rated yet |
0
-
Adjuvant combo shows potential for universal influenza vaccine
Jun 08, 2011 |
not rated yet |
0
-
Researchers discover new way to boost vaccines, seeks patent
Aug 04, 2010 |
not rated yet |
0
-
New cell type offers new hope
Jun 14, 2011 |
not rated yet |
0
-
What is the function of the protein CD20?
Dec 22, 2009 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
21 hours ago
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
-
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013
-
Alcohol and acetaminophen
May 13, 2013
-
Marie Curie's leukemia
May 13, 2013
- More from Physics Forums - Medical Sciences
More news stories
Now we know why old scizophrenia medicine works on antibiotics-resistant bacteria
In 2008 researchers from the University of Southern Denmark showed that the drug thioridazine, which has previously been used to treat schizophrenia, is also a powerful weapon against antibiotic-resistant bacteria such as ...
Medical research
May 17, 2013 |
3.7 / 5 (3) |
0
|
SUMO wrestling cells reveal new protective mechanism target for stroke
Scientists investigating the interaction of a group of proteins in the brain responsible for protecting nerve cells from damage have identified a new target that could increase cell survival.
Medical research
May 17, 2013 |
5 / 5 (1) |
0
How serotonin receptors can shape drug effects, from LSD to migraine medication
New findings by researchers carrying out experiments at the U.S. Department of Energy Office of Science's Advanced Photon Source (APS) help explain why some drugs that interact with two kinds of human serotonin ...
Medical research
May 17, 2013 |
not rated yet |
0
|
Preventing blood poisoning
Peptide molecules derived from the body's natural immune system can help boost the body's defence against life-threatening blood poisoning, joint University research has uncovered.
Medical research
May 17, 2013 |
4 / 5 (1) |
0
|
New mechanism to prevent type 2 diabetes in obese individuals
A new Montréal study conducted by Dr. May Faraj, associate research professor at the Université de Montréal and invited scientist at the IRCM, along with her research team and medical collaborators, shows ...
Medical research
May 17, 2013 |
not rated yet |
0
|
Consuming coffee linked to lower risk of detrimental liver disease, study finds
Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune liver disease, Mayo Clinic research shows. The findings were being presented at the Digestive Disease ...
Ketamine shows significant therapeutic benefit in people with treatment-resistant depression
Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the ...
New research identifies risks, interventions for children's GI health
An increasing number of U.S. children are experiencing gastrointestinal issues that require interventions to resolve, according to research presented at Digestive Disease Week (DDW).
US psychiatry gets makeover in new manual
The latest makeover to a massive psychiatric tome honored by some, reviled by others and even called the "Bible" of mental disorders is being released Saturday with a host of new changes.
New case of SARS-like virus in Saudi: ministry
A new case of the deadly coronavirus has been detected in Saudi Arabia where 15 people have already died after contracting it, the health ministry announced on Saturday on its Internet website.
AIDS science at 30: 'Cure' now part of lexicon
Big names in medicine are set to give an upbeat assessment of the war on AIDS on Tuesday, 30 years after French researchers identified the virus that causes the disease.